Kroger Trims 2026 Sales Outlook on Pharmacy Headwinds

Kroger posted a quarterly revenue of $34.62 billion, a 2% year-over-year increase, while adjusted net income declined to $667 million from $695 million in the prior year. Despite the drop in total profit, the reduction in share count lifted adjusted earnings per share to $1.09, compared with $1.04 a year earlier. The company’s performance slightly exceeded consensus estimates, which had projected sales of $34.65 billion and adjusted EPS of $1.06.

Same-store sales, excluding fuel, rose marginally to just under $30 billion, a slower pace than the 3.4% gain recorded in the second quarter of 2025. Management noted that excluding fuel sales, the divestiture of the Vitacost e-commerce unit, and the closure of several fulfillment centers, organic sales growth would have been only 0.1%. This indicates that structural changes and one-time items masked a nearly flat underlying business performance.

Margin pressures offset by digital gains

Gross margin remained stable at 22.4%, as higher fuel sales volumes were counterbalanced by increased transportation costs. The company also faced headwinds from higher shrink, defined as inventory loss due to theft, damage, or spoilage. These negative factors were partially offset by a 20% surge in adjusted e-commerce sales and a favorable mix in pharmacy volumes, which helped sustain overall profitability despite the cost pressures.

The offsetting dynamics in the quarter reflected a broader struggle to maintain growth in a low-margin sector. While digital channels expanded rapidly, traditional retail metrics showed limited momentum. This mix of rising costs and selective growth areas resulted in a net outcome where positive and negative factors largely canceled each other out, leading to the modest top-line increase reported in the earnings release.

Guidance reduced due to regulatory drag

Kroger lowered its full-year 2026 same-store sales growth guidance to 0.2%–0.8%, down from the previous estimate of 1%–2%. This adjustment stems from an estimated 140-basis-point drag on pharmacy sales caused by changes under the Inflation Reduction Act. The company maintained its adjusted EPS forecast at $5.10–$5.30, implying year-over-year growth of at least 5%, a significant increase for a retailer with historically slow growth.

The reduction in sales guidance highlights the direct impact of government policy on the company’s pharmacy segment. By adjusting for the regulatory headwinds, management provided a more conservative outlook for revenue growth. However, the stable EPS target suggests that cost management and other business segments are expected to support profitability even as pharmacy sales face pressure from legislative changes.

Dividend growth and buybacks continue

Kroger reaffirmed its commitment to shareholder returns, signaling it will continue to increase its quarterly dividend. The company raised its payout by 11% to $0.39 per share, marking the 20th consecutive year of annual dividend increases. This dividend yield of 2.5% significantly exceeds the S&P 500 average of under 1.1%, reflecting the company’s stable cash flow profile.

Additionally, Kroger plans to deploy the remaining $800 million of its $2 billion share repurchase authorization. This buyback activity, combined with the dividend increase, demonstrates the company’s ability to generate sufficient free cash flow to support capital returns. The source GN markets/earnings (en-US) notes that these actions are viewed as a positive signal for long-term investors, despite the modest operational growth in the recent quarter.